SGN-B6A Antibody
SGN-B6A is an antibody-drug conjugate (ADC) targeting integrin β-6 (ITGB6) via the monoclonal antibody Sigvotatug, delivering the cytotoxic payload MMAE. It demonstrates potent anti-tumor activity in ITGB6-expressing cancer models, supporting its investigation in preclinical research for cancers such as pancreatic and non-small cell lung carcinoma.
Product Specifications
Target
Integrin, Antibody-Drug Conjugates (ADCs)
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
